The metabolic hormone adiponectin affects the correlation between nutritional status and pneumococcal vaccine response in vulnerable indigenous children
- PMID: 35862344
- PMCID: PMC9302759
- DOI: 10.1371/journal.pone.0270736
The metabolic hormone adiponectin affects the correlation between nutritional status and pneumococcal vaccine response in vulnerable indigenous children
Abstract
Background: Almost 200 million children worldwide are either undernourished or overweight. Only a few studies have addressed the effect of variation in nutritional status on vaccine response. We previously demonstrated an association between stunting and an increased post-vaccination 13-valent pneumococcal conjugate vaccine (PCV13) response. In this prospective study, we assessed to what extent metabolic hormones may be a modifier in the association between nutritional status and PCV13 response.
Methods: Venezuelan children aged 6 weeks to 59 months were vaccinated with a primary series of PCV13. Nutritional status and serum levels of leptin, adiponectin and ghrelin were measured upon vaccination and their combined effect on serum post-vaccination antibody concentrations was assessed by generalized estimating equations multivariable regression analysis.
Results: A total of 210 children were included, of whom 80 were stunted, 81 had a normal weight and 49 were overweight. Overweight children had lower post-vaccination antibody concentrations than normal weight children (regression coefficient -1.15, 95% CI -2.22 --0.072). Additionally, there was a significant adiponectin-nutritional status interaction. In stunted children, higher adiponectin serum concentrations were associated with lower post-PCV13 antibody concentrations (regression coefficient -0.19, 95% CI -0.24 --0.14) while the opposite was seen in overweight children (regression coefficient 0.14, 95% CI 0.049-0.22).
Conclusion: Metabolic hormones, in particular adiponectin, may modify the effect of nutritional status on pneumococcal vaccine response. These findings emphasize the importance of further research to better understand the immunometabolic pathways underlying vaccine response and enable a future of optimal personalized vaccination schedules.
Conflict of interest statement
Pfizer Venezuela only provided financial support in the form of vaccine (PCV13) supply and research materials. Lilly M. Verhagen was supported by a Clinical Research Talent fellowship of the UMC Utrecht, The Netherlands. Further, Lilly Verhagen was granted a Pichichero Family Foundation Vaccines for Children Initiative Research Award from the Pediatric Infectious Diseases Society Foundation. All authors had no significant competing financial, professional or personal interests that might have influenced this research.
Figures


Similar articles
-
Stunting correlates with high salivary and serum antibody levels after 13-valent pneumococcal conjugate vaccination of Venezuelan Amerindian children.Vaccine. 2016 Apr 29;34(20):2312-20. doi: 10.1016/j.vaccine.2016.03.066. Epub 2016 Mar 29. Vaccine. 2016. PMID: 27036512
-
Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccine.Pediatr Infect Dis J. 2014 Oct;33(10):1065-76. doi: 10.1097/INF.0000000000000459. Pediatr Infect Dis J. 2014. PMID: 25093973 Clinical Trial.
-
Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2010 Dec 10;59(RR-11):1-18. MMWR Recomm Rep. 2010. PMID: 21150868
-
Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.Clin Microbiol Infect. 2013 Oct;19 Suppl 1:1-9. doi: 10.1111/1469-0691.12320. Clin Microbiol Infect. 2013. PMID: 24083785 Review.
-
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13®].Drugs. 2010 Oct 22;70(15):1973-86. doi: 10.2165/11205110-000000000-00000. Drugs. 2010. PMID: 20883054 Review.
References
-
- WHO/Unicef/World Bank. State of the world’s vaccines and immunization, 3rd ed. Geneva, World Health Organisation. 2009.
-
- World Health Organisation. Factsheet Malnutrition [Internet]. 2018 [cited 2020 Apr 14]. Available from: https://www.who.int/news-room/fact-sheets/detail/malnutrition
-
- World Health Organisation. Nutrition; Double burden of malnutrition [Internet]. [cited 2020 Apr 14]. Available from: https://www.who.int/nutrition/double-burden-malnutrition/en/
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical